(Total Views: 434)
Posted On: 09/27/2021 11:24:25 PM
Post# of 30067
$TOMDF should be cash flow positive soon Q4 / Q1 22
Marketing expenses for Tollovid & Tollovir handed off to the subsidiary as to not burden the parent company.
Also said about raising capital
"Raise capital into subsidiary which we are doing
We are executing on that strategy."
Excellent interview.
$AMBS will benefit from the uplist which seems like it will happen within the next 3 months or early Q1 22.
Marketing expenses for Tollovid & Tollovir handed off to the subsidiary as to not burden the parent company.
Also said about raising capital
"Raise capital into subsidiary which we are doing
We are executing on that strategy."
Excellent interview.
$AMBS will benefit from the uplist which seems like it will happen within the next 3 months or early Q1 22.
(0)
(0)
